Stoke Therapeutics Inc buy Jefferies Financial Group Inc.
Start price
18.07.25
/
50%
€11.40
Target price
18.07.26
€25.81
Performance (%)
156.14%
Price
13.03.26
€29.20
Summary
This prediction is currently active. The BUY prediction by Jefferies_Financial_ for Stoke Therapeutics Inc has seen massive gains of 156.14%. This prediction currently runs until 18.07.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Stoke Therapeutics Inc | -1.351% | -1.351% |
| iShares Core DAX® | -1.104% | -6.084% |
| iShares Nasdaq 100 | 0.328% | 2.327% |
| iShares Nikkei 225® | -1.082% | -7.987% |
| iShares S&P 500 | -0.055% | 0.880% |
Comments by Jefferies_Financial_ for this prediction
In the thread Stoke Therapeutics Inc diskutieren
Stoke Therapeutics, Inc. (NASDAQ: STOK) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $30.00 price target on the stock.
Ratings data for STOK provided by MarketBeat